These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta. Rouine-Rapp K; Mello DM; Hanley FL; Mohan Reddy V; Soifer S Pediatr Crit Care Med; 2003 Jul; 4(3):327-32. PubMed ID: 12831415 [TBL] [Abstract][Full Text] [Related]
10. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure. Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011 [TBL] [Abstract][Full Text] [Related]
11. Enalaprilat in acute intractable heart failure after myocardial infarction: a prospective, consecutive sample, before-after trial. Tohmo H; Karanko M; Korpilahti K; Scheinin M; Viinamäki O; Neuvonen P Crit Care Med; 1994 Jun; 22(6):965-73. PubMed ID: 8205829 [TBL] [Abstract][Full Text] [Related]
13. Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events. Brunner-La Rocca HP; Weilenmann D; Kiowski W; Maly FE; Follath F J Pharmacol Exp Ther; 1999 Apr; 289(1):565-71. PubMed ID: 10087051 [TBL] [Abstract][Full Text] [Related]
14. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience. Navookarasu NT; Rahman AR; Abdullah I Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses. Gardner SY; Atkins CE; Sams RA; Schwabenton AB; Papich MG J Vet Intern Med; 2004; 18(2):231-7. PubMed ID: 15058776 [TBL] [Abstract][Full Text] [Related]
16. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group. Vítovec J; Spinar J Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II and sympathetic activity in patients with congestive heart failure. Goldsmith SR; Hasking GJ; Miller E J Am Coll Cardiol; 1993 Apr; 21(5):1107-13. PubMed ID: 8384645 [TBL] [Abstract][Full Text] [Related]
18. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects. Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369 [TBL] [Abstract][Full Text] [Related]
19. OACE inhibition does not interfere with acute extrarenal or renal potassium disposal in chronic renal failure. Zwettler U; Fliser D; Nowicki M; Ritz E Eur J Clin Pharmacol; 1994; 46(3):185-9. PubMed ID: 8070497 [TBL] [Abstract][Full Text] [Related]
20. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure. Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]